20 May 2013
Keywords: dovebid, conduct, auction, pfizer, japan, usa-based, global
Article | 14 January 2008
DoveBid, a USA-based global provider of capital asset auction and
valuation services, will conduct a series of biotechnology and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 January 2008
17 May 2013
© 2013 thepharmaletter.com